Date: 2017 / Author/Creator: Weitzman, Ron - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Date 2017 Author/Creator Weitzman, Ron

1. A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinoma. (September 2017)

Authors:: Vergote, Ignace B.; Smith, David C.; Berger, Raanan; Kurzrock, Razelle; Vogelzang, Nicholas J.; Sella, Avishay; Wheler, Jennifer; Lee, Yihua; Foster, Paul G.; Weitzman, Ron; Buckanovich, Ronald J.
Journal:: European journal of cancer
Issue:: Volume 83(2017)
Page Start:: 229
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy. Issue 2 (14th August 2017)

Authors:: Wen, Patrick Y; Drappatz, Jan; de Groot, John; Prados, Michael D; Reardon, David A; Schiff, David; Chamberlain, Marc; Mikkelsen, Tom; Desjardins, Annick; Holland, Jaymes; Ping, Jerry; Weitzman, Ron; Cloughesy, Timothy F
Journal:: Neuro-oncology
Issue:: Volume 20:Issue 2(2018)
Page Start:: 249
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy. Issue 2 (3rd October 2017)

Authors:: Cloughesy, Timothy F; Drappatz, Jan; de Groot, John; Prados, Michael D; Reardon, David A; Schiff, David; Chamberlain, Marc; Mikkelsen, Tom; Desjardins, Annick; Ping, Jerry; Holland, Jaymes; Weitzman, Ron; Wen, Patrick Y
Journal:: Neuro-oncology
Issue:: Volume 20:Issue 2(2018)
Page Start:: 259
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗